← Back to feedRead original →
VERIFIEDET Finance·positive
Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilar
AI Summary
- ·Biocon Biologics has received marketing approval for its pegfilgrastim biosimilar in Japan.
- ·The drug is used to reduce infection risks after chemotherapy.
- ·Sandoz KK will exclusively promote and distribute the biosimilar in Japan.